A new report from the American Medical Association reveals that doctors are increasingly likely to work for larger provider groups and hospitals, as single specialty practices slowly disappear. 

After years of trying to catch up with the competition, Boston Scientific is moving on. The company is no longer seeking approval from the FDA or any other regulatory agencies for these devices, and all global sales have been discontinued.

The resolution urges the AMA to advocate for separate payment for certain services using supplies priced above $500, as well as those containing high-cost equipment. 

One of the world's largest medtech companies could make a major move within the next 18 months. Que Dallara, the current president of Medtronic’s diabetes business, would be the new company's CEO.

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

KFF Health News interviewed multiple independent pharmacies for a new report, detailing their basements full of generic and specialty drugs as a hedge against supply shocks. 

A report by researchers at Trilliant Health found that common symptoms—such as cough, nausea and rash—are often coded as complex medical events, resulting in higher reimbursement rates.

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.